SBFM Earnings

Quarterly EPS
$-508.78
Q4 2024
$-88.00
Q1 2025
$-78.80
Q2 2025
$-38.80
Q3 2025
$-87.87
Q4 2025
$-50.00
Q1 2026
$-23.00
Q2 2026
$-5.20
Q3 2026
Latest Revenue9.4M
Latest Net Income-1223940
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q3 2026-$5.209.4M-1223940+0.3%+86.6%
Q2 2026-$23.009.3M-1564048-1.6%+70.8%
Q1 2026-$50.008.1M-1243869-9.1%+43.2%
Q4 2025-$87.878.6M-2140927-10.6%+82.7%
Q3 2025-$38.809.4M-883820+11.6%+79.4%
Q2 2025-$78.809.4M-1770834+1.2%+96.0%
Q1 2025-$88.008.9M-1179771+18.0%+78.0%
Q4 2024-$508.789.6M-2158212+24.9%+97.0%
Q3 2024-$188.008.4M-1197803——
Q2 2024-$1,988.009.3M-494300——
Q1 2024-$400.007.5M-1283801——
Q4 2023-$16,935.877.7M-1250024——
Sunshine Biopharma (SBFM) — Earnings